We spoke with experts to learn about the different types of exercise that can be beneficial for people taking GLP-1 medications
H.MichaudJ.BuotV.StefanchikB.PlotkinM
The schedule followed two key acceptance phases: February 2025 Project launch February 2026 Acceptance 1 (86%), followed by an additional tenweek period for testing and adjustments May 2026 Acceptance 2 (14%), followed by the final tenweek window before full delivery These periods covered FAT, integration work, documentation finalisation and site readiness to ensure seamless transition to commissioning activities
Studies show that participants lost an average of 15-20% of their body weight over 72 weeks, with weight changes typically beginning within the first few months of treatment
Sau 10 n 20 pht, g mt n ra v v nh phn tinh cht cn li ti thm thu ht
Availability may vary slightly based on location, scheduling and clinical appropriateness